Your browser doesn't support javascript.
loading
Long-Term Vaccination and Treatment Strategies for COVID-19 Disease and Future Coronavirus Pandemics.
Sahebkar, Amirhossein; Jamialahmadi, Tannaz; Rahmoune, Hassan; Guest, Paul C.
Afiliação
  • Sahebkar A; Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Jamialahmadi T; Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Rahmoune H; School of Medicine, The University of Western Australia, Perth, WA, Australia.
  • Guest PC; Department of Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Adv Exp Med Biol ; 1412: 27-49, 2023.
Article em En | MEDLINE | ID: mdl-37378760
ABSTRACT
The appearance of new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with increased infectivity and immune escape capabilities has allowed continuation of the COVID-19 pandemic for the foreseeable future. This review describes the worldwide efforts aimed at developing new vaccination and treatment strategies to keep pace with these variants as they emerge. In the case of vaccines and monoclonal antibody-based therapeutics, we describe the development of variant-specific, multivalent, and universal coronavirus directed approaches. Existing treatment approaches consist of repurposed medicines, such as antiviral compounds and anti-inflammatory agents, although efforts are underway to develop new ways of preventing or minimizing the effects of infection with the use of small molecules that disrupt binding the SARS-CoV-2 virus to host cells. Finally, we discuss the preclinical and clinical testing of natural products from medicinal herbs and spices, which have demonstrated anti-inflammatory and antiviral properties and therefore show potential as novel and safe COVID-19 treatment approaches.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Revista: Adv Exp Med Biol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Revista: Adv Exp Med Biol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irã